1. RNA-seq based transcriptome analysis of EHMT2 functions in breast cancer.
- Author
-
Kim, Kwangho, Ryu, Tae Young, Ryu, Jea-Woon, Han, Tae-Su, Jung, Cho-Rok, Son, Mi-Young, Kim, Dae-Soo, and Cho, Hyun-Soo
- Subjects
- *
BREAST cancer , *TRIPLE-negative breast cancer , *GENE ontology , *HORMONE therapy , *CELL migration - Abstract
For breast cancer treatment, hormone therapy is effective for hormone receptor-positive breast cancer but not for TNBC (triple-negative breast cancer). Thus, many researchers have attempted to identify more effective therapeutic candidates for all subtypes of breast cancer. In this study, we established an RNA-seq analytical pipeline to analyze the subtype-specific functions of EHMT2 in the MB231 and MCF7 cell lines. After EHMT2 knockdown, we identified subtype-specific DEGs (differentially expressed genes) and overlapping DEGs. Through GO (Gene Ontology) analysis, GSEA (gene set enrichment analysis), and KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis using the DEGs, we identified the subtype-specific functions of EHMT2 in the MB231 and MCF7 cell lines. Therefore, herein, we suggest that EHMT2 is an attractive therapeutic target for the treatment of all types of breast cancer. • EHMT2 knockdown suppressed cell proliferation and migration/invasion in MB231 and MCF7. • In RNA-seq analysis, EHMT2 have cell type specific functions in MB231 and MCF7. • EHMT2 is an attractive therapeutic target for treating all types of breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF